BKM Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.77M Buy
6,573
+858
+15% +$342K 0.9% 29
2026
Q2
$2.07M Sell
5,715
-627
-10% -$215K 0.73% 35
2026
Q1
$2.23M Sell
6,342
-185
-3% -$66K 0.81% 36
2025
Q4
$2.14M Sell
6,527
-819
-11% -$260K 0.78% 39
2025
Q3
$2.07M Sell
7,346
-56
-0.8% -$16.2K 0.76% 41
2025
Q2
$2.07M Buy
7,402
+267
+4% +$75.6K 0.81% 35
2025
Q1
$2.22M Buy
7,135
+119
+2% +$35.1K 0.92% 34
2024
Q4
$1.83M Buy
7,016
+454
+7% +$135K 0.75% 37
2024
Q3
$2.11M Buy
6,562
+194
+3% +$63.5K 0.86% 29
2024
Q2
$1.99M Buy
6,368
+440
+7% +$129K 0.96% 29
2024
Q1
$1.69M Buy
5,928
+855
+17% +$250K 0.72% 40
2023
Q4
$1.46M Buy
+5,073
New +$1.38M 0.62% 46

Other funds holding AMGN

BKM Wealth Management's AMGN Position: Q3 2026 in Review

BKM Wealth Management increased its Amgen (AMGN) stake by 15% in Q3 2026, buying an estimated $342K and bringing the position to 6,573 shares worth $2.77M. The position accounts for 0.9% of the portfolio, ranked #29.

BKM Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • BKM Wealth Management held 6,573 shares of Amgen worth $2.77M as of Q3 2026.
  • BKM Wealth Management bought 858 Amgen shares in Q3 2026, an estimated $342K.
  • Amgen made up 0.9% of BKM Wealth Management's portfolio in Q3 2026, its #29 holding.
  • BKM Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on BKM Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.